BIOMAT Database Logo BIOMAT Database Logo

Enhanced binding activity observed between anti-carcinoembryonic monoclonal antibodies. 1986

R Wellerson, and P Kaplan

Six anti-carcinoembryonic monoclonal antibodies (CEA MAbs) were isolated and characterized. Through blocking studies, only two were found to share the same epitope, indicating that CEA has at least five different epitopic sites. One of the group, 31C5A4 was found to enhance greatly the binding of CEA by 20C2H1. When (31C5A4) was fragmented, both the F(ab')2 and Fab bound CEA and blocked the binding of CEA by intact 31C5A4; however, only F(ab')2 was able to enhance. Fab could be induced to enhance after being restructured into a divalent form with rabbit anti-mouse (RAM) (heavy and light chains). The addition of the enhancing MAb (31C5A4) to the CEA-20C2H1 RAM-staph A (SA) complex caused a striking decrease in the rate at which the CEA dissociated from the complex. The data suggest that the enhancement observed with these anti-CEA MAbs was the result of the formation of a stable cyclic complex.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

R Wellerson, and P Kaplan
Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodies.
February 1990, Cancer research,
R Wellerson, and P Kaplan
Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen.
December 1982, Molecular immunology,
R Wellerson, and P Kaplan
Binding sites of monoclonal anti-carbohydrate antibodies.
January 1988, Current topics in microbiology and immunology,
R Wellerson, and P Kaplan
Monoclonal antibodies in carcinoembryonic antigen assay.
January 1984, La Ricerca in clinica e in laboratorio,
R Wellerson, and P Kaplan
Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
March 1987, Cancer research,
R Wellerson, and P Kaplan
Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies.
May 1991, Cancer research,
R Wellerson, and P Kaplan
Potentiation of anti-carcinoembryonic antigen immunotoxin cytotoxicity by monoclonal antibodies reacting with co-expressed carcinoembryonic antigen epitopes.
June 1988, Journal of immunology (Baltimore, Md. : 1950),
R Wellerson, and P Kaplan
Plate binding assay for monoclonal anti-receptor antibodies.
March 1985, Endocrinology,
R Wellerson, and P Kaplan
ADCC activity of monoclonal anti-D antibodies.
April 1988, Revue francaise de transfusion et immuno-hematologie,
R Wellerson, and P Kaplan
ADCC activity of monoclonal anti-D antibodies.
January 1996, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
Copied contents to your clipboard!